XML 53 R46.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholders' Equity - Additional Information (Details) - USD ($) |  |  |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jul. 24, 2024 | Jul. 19, 2024 | Jul. 18, 2024 | Jul. 17, 2024 | Jul. 10, 2024 | Jun. 17, 2024 | Apr. 16, 2024 | Aug. 16, 2023 | Oct. 31, 2024 | Sep. 30, 2024 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024 | Dec. 31, 2024 | Aug. 06, 2024 | Jun. 28, 2024 | Apr. 29, 2024 | Apr. 08, 2024 | Jan. 29, 2024 | Nov. 15, 2023 | Dec. 31, 2021 | Dec. 15, 2021
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,565,392 |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  | $ 3.9 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  | $ 3.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expire date |  | Jul. 20, 2026 |  | Jul. 24, 2026 | Jul. 17, 2026 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment per warrant (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 0.125 |  |  |  |  |  |  |  |  |  |
Series B warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  |  |  |  |  |  | 18 months |  |  |  |  |  |  |  |  |  |
Aggregate gross (in Dollars) |  |  |  |  |  |  |  |  |  |  |  | $ 9,000,000 |  |  |  |  |  |  |  |  |  |
Series A warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  |  |  |  |  |  | 5 years 6 months |  |  |  |  |  |  |  |  |  |
Series A and Series B Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |  |  |  |
Pre Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.349 |  |  |  |
Common Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants or rights exercisable date |  |  |  |  |  |  |  |  |  |  |  | Apr. 10, 2029 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.9375 |  |  |  |  |  | $ 2.35 |  |  |  |
Warrant term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |
Class A common stock warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment per warrant (in Dollars per share) |  |  |  |  |  | $ 0.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series C warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.25 |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series D Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 118,852 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.25 |  |  |  |  |  |  |  |  |  |
Series C Warrants and Series D warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  | 24 months |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
June Inducement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deemed dividend to common stockholders (in Dollars) |  |  |  |  |  |  |  |  |  |  |  | $ 8,500,000 |  |  |  |  |  |  |  |  |  |
June Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 49,130 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.9375 |  |  |  |  |  |  |  |  |  |
July Private Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,236,026 |  |  |  |  |  |  |
July Offering Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 156,522 |  |  |  |  |  |  |
July Ordinary Course Placement Agent [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 172,844 |  |  |  |  |  |  |
Black-Scholes pricing model [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  | $ 52.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrants (in Dollars) |  |  |  |  |  |  |  | $ 800,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock voting rights |  |  |  |  |  |  |  |  |  |  |  | one |  |  |  |  |  |  |  |  |  |
Warrants to purchase |  |  |  |  |  |  |  |  |  |  |  | 10,640 |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 0.001 |  | $ 0.001 |  |  |  |  |  |  |  |
Warrants or rights exercisable date |  |  |  |  |  |  |  |  |  |  |  | Aug. 12, 2021 |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  | 150,000 | 3,395,782 |  |  |  |  |  | 154,894 |  |  |  |  |  |  |  |  |  | 238,549
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  | 6,802,668 |  |  |  | 3,563,764 | 4,967,470 |  | 145,020 | 501,821 |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  | $ 2.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  | 24 months |  |  |  |  |  | 4 years 6 months |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares | 7.00% |  |  | 7.00% |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 5.0313 |  |  |  |  |  |  |  |  |  |
Reverse stock split | 162,344 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate shares |  |  | 4.025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issued |  |  |  |  |  |  |  |  |  |  |  | 156,522 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 120 |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 118,852 |  |  |  |  |  |  |  |  |  | 116,935
Fair value of warrants (in Dollars) |  |  |  |  |  |  |  |  |  |  |  | $ 500,000 |  |  |  |  |  |  |  |  |  |
Payment per warrant (in Dollars per share) |  |  |  |  |  |  | $ 0.125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |
Reverse stock split |  |  |  |  | 10,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Series B warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 242,425 |  |
Class A Common Stock [Member] | Series A warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 242,425 |  |
Class A Common Stock [Member] | Placement agent warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 167,982 |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 167,982 |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.25 |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Apr. 18, 2029 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Pre Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.001 |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,572,894 |  |  |  |
Class A Common Stock [Member] | Class A common stock warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  | 4,799,488 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Series C warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  | 2,399,744 |  |  |  |  | 2,349,744 |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,399,744 |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Apr. 18, 2029 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Series D Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  | 2,399,744 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,399,744 |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |
Exercise of remaining shares |  |  |  |  |  |  |  |  |  |  |  | 1,697,891 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | June Inducement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 926,596 |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,395,782 |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.5 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jun. 18, 2026 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | June Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 49,130 |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 167,982 |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.9375 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jun. 18, 2026 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Placement Agent Warrants June 2024 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 118,852 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.25 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jun. 18, 2026 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | July Private Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 2,236,026 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.9 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jul. 20, 2026 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | July Offering Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 156,522 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 5.0313 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jul. 20, 2026 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | First Tranche July Ordinary Course Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 10,500 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.125 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jul. 17, 2026 |  |  |  |  |  |  |  |  |  |
Class A Common Stock [Member] | Second Tranche July Ordinary Course Placement Agent Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 162,344 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 3.125 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jul. 24, 2026 |  |  |  |  |  |  |  |  |  |
Class B Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock voting rights |  |  |  |  |  |  |  |  |  |  |  | five |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 0.001 |  | $ 0.001 |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 49,130 |  |  |  |  |  |  |  |  |  |
Common Stock [Member] | Common Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,212,766 |  |  |  |
Common Stock [Member] | Series D Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Percentage of aggregate number of shares |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |
Common Stock [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options exercised |  |  |  |  |  |  |  |  |  |  | 4,799,488 |  | 4,799,488 |  |  |  |  |  |  |  |  |
Stockholders shares converted |  |  |  |  |  |  |  |  |  |  |  | 0 | 1,555 | 1,555 |  |  |  |  |  |  |  |
Reverse stock split |  |  |  |  |  |  |  |  |  |  | 66,970 |  | 66,970 |  |  |  |  |  |  |  |  |
Common Stock [Member] | Class B Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders shares converted |  |  |  |  |  |  |  |  |  |  |  |  | (1,555) | 1,555 |  |  |  |  |  |  |  |
Public offering [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 639,872 |  |  |  |
Public offering [Member] | Class A Common Stock [Member] | Underwriters Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 5,536 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 120 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Feb. 12, 2026 |  |  |  |  |  |  |  |  |  |
Underwriters [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,576 |
2021 private placement offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 116,935 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  | $ 1 | $ 1 |  |  |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
2021 private placement offering [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 116,935 |  |  |  |  |  |  |  |  |  |
2021 private placement offering [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 4,679 |  |  |  |  |  |  |  |  |  | 116,935
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 175 |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) |  |  |  |  |  |  |  |  | $ 2,858 | $ 114,077 |  |  |  |  |  |  |  |  |  |  |  |
Aggregate gross (in Dollars) |  |  |  |  |  |  |  |  | $ 2,858,000 | $ 114,077 |  |  |  |  |  |  |  |  |  |  |  |
2021 private placement offering [Member] | Class A Common Stock [Member] | Underwriters Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 4,679 |  |  |  |  |  |  |  |  |  | 4,679
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 175 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Dec. 01, 2026 |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, purchase price per share |  |  |  |  |  |  |  |  |  |  |  | $ 16.5 |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  | 236,500 |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] | Series B warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  | 242,425 |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  |  |  |  |  |  | 18 months |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] | Series A warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  | 242,425 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 16.5 |  |  |  |  |  |  |  |  |  |
Warrant term |  |  |  |  |  |  |  |  |  |  |  | 5 years 6 months |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] | Pre Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 0.01 |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 16,971 |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] | Class A Common Stock [Member] | Placement agent warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 16,971 |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16,971 |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 20.625 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Oct. 11, 2028 |  |  |  |  |  |  |  |  |  |
October 2023 registered direct offering [Member] | Class A Common Stock [Member] | Pre Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, purchase price per share |  |  |  |  |  |  |  |  |  |  |  | $ 16.49 |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 5,925 |  |  |  |  |  |  |  |  |  |
December 2023 registered direct offering [Member] | Underwriters Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 9,489 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 21.813 |  |  |  |  |  |  |  |  |  |
December 2023 registered direct offering [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 135,531 |  |  |  |  |  |  | 135,531 |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  | 135,531 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 16.2 |  |  |  |  |  |  |  |  |  |
December 2023 registered direct offering [Member] | Class A Common Stock [Member] | Placement agent warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 9,489 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 21.813 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Dec. 20, 2028 |  |  |  |  |  |  |  |  |  |
December 2023 registered direct offering [Member] | Class A Common Stock [Member] | Investor warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 135,531 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 16.2 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Jun. 22, 2029 |  |  |  |  |  |  |  |  |  |
December 2023 registered direct offering [Member] | Class A Common Stock [Member] | Underwriters Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,489 |  |  |
April 2024 Public Offering [Member] | Class A Common Stock [Member] | Placement agent warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 154,894 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.9375 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Apr. 08, 2029 |  |  |  |  |  |  |  |  |  |
April 2024 Public Offering [Member] | Class A Common Stock [Member] | Common Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  |  |  |  |  |  |  |  | 297,872 |  |  |  |  |  |  |  |  |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  | $ 2.35 |  |  |  |  |  |  |  |  |  |
Expire date |  |  |  |  |  |  |  |  |  |  |  | Apr. 10, 2029 |  |  |  |  |  |  |  |  |  |
July Registered Direct Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Public offering shares |  |  | 2,236,026 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
July Registered Direct Offering [Member] | Class A Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants outstanding |  |  |  |  |  |  |  |  |  |  |  | 2,236,026 |  |  |  |  |  |  |  |  |  |
Note Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant purchase shares |  |  |  |  | 2,319,186 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Note Warrant [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stockholders’ Equity [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds (in Dollars) |  |  |  |  |  |  |  |  |  |  |  | $ 6,300,000 |  |  |  |  |  |  |  |  |  |

X
- Definition Number of shares exercised. + References No definition available. + Details
Name: | lgvn_ExerciseOfRemainingShares
Namespace Prefix: | lgvn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payment per warrant. + References No definition available. + Details
Name: | lgvn_PaymentPerWarrant
Namespace Prefix: | lgvn_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of aggregate number of shares. + References No definition available. + Details
Name: | lgvn_PercentageOfAggregateNumberOfShares
Namespace Prefix: | lgvn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants to purchase. + References No definition available. + Details
Name: | lgvn_WarrantsToPurchase
Namespace Prefix: | lgvn_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 480 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 272 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 + Details
Name: | us-gaap_ClassOfStockLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the warrants or rights are exercisable, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of other common stock instruments held by shareholder, including, but not limited to, exchangeable shares. + References No definition available. + Details
Name: | us-gaap_CommonStockOtherSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_CommonStockVotingRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_ConversionOfStockSharesConverted1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expiration, mandatory redemption, or due date, in YYYY-MM-DD format, of the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of units sold in a public offering of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 4.F) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-5 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_PartnersCapitalAccountUnitsSoldInPublicOffering
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromDebtNetOfIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow from capital contributions to an entity associated with a dividend reinvestment plan. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Reduction in the number of shares during the period as a result of a reverse stock split. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of share options (or share units) exercised during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_WarrantExercisePriceIncrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=us-gaap_SeriesBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=us-gaap_SeriesAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_SeriesAAndSeriesBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_PreFundedWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_CommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_ClassACommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_SeriesCWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_SeriesDWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_SeriesCWarrantsAndSeriesDWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_JuneInducementWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_JunePlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_JulyPrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_JulyOfferingPlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_JulyOrdinaryCoursePlacementAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueConsensusPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_PlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_PlacementAgentWarrants1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_FirstTrancheJulyOrdinaryCoursePlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_SecondTrancheJulyOrdinaryCoursePlacementAgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_UnderwritersWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=lgvn_UnderwritersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=lgvn_TwoThousandTwentyOnePIPEOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=lgvn_October2023RegisteredDirectOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=lgvn_December2023OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=lgvn_InvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=lgvn_AprilTwoThousandTwentyFourPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=lgvn_JulyRegisteredDirectOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |